A novel first-trimester screening algorithm, validated to predict preterm preeclampsia, incorporates mean arterial blood pressure, Doppler ultrasound-measured maternal uterine artery resistance, and Placental Growth Factor (PlGF) levels [5, 6]. The gene discussed is PGF; the disease is preeclampsia.